Deck 29: Treatment of Psychotic Disorders
سؤال
سؤال
فتح الحزمة
قم بالتسجيل لفتح البطاقات في هذه المجموعة!
Unlock Deck
Unlock Deck
1/2
العب
ملء الشاشة (f)
Deck 29: Treatment of Psychotic Disorders
Extrapyramidal symptoms occur with antipsychotics due to:
A) Inhibition of receptors in the mesolimbic region of the brain
B) A compensatory response in the mesolimbic region due to receptor blockade
C) Blockade of muscarinic cholinergic receptors
D) Blocking of dopamine receptors in the basal ganglia
E) Up regulation of dopamine receptors
A) Inhibition of receptors in the mesolimbic region of the brain
B) A compensatory response in the mesolimbic region due to receptor blockade
C) Blockade of muscarinic cholinergic receptors
D) Blocking of dopamine receptors in the basal ganglia
E) Up regulation of dopamine receptors
Blocking of dopamine receptors in the basal ganglia
Atypical antipsychotics differ from typical antipsychotics in that:
A) Atypical antipsychotics have a smaller therapeutic window
B) Atypical antipsychotics block more D₂ receptors than typical antipsychotics
C) Atypical antipsychotics block 5-HT₂A as well as D₂ receptors
D) Atypical antipsychotics have a higher incidence of adverse effects
E) Atypical antipsychotics have no known side effects
A) Atypical antipsychotics have a smaller therapeutic window
B) Atypical antipsychotics block more D₂ receptors than typical antipsychotics
C) Atypical antipsychotics block 5-HT₂A as well as D₂ receptors
D) Atypical antipsychotics have a higher incidence of adverse effects
E) Atypical antipsychotics have no known side effects
Atypical antipsychotics block 5-HT₂A as well as D₂ receptors

